Vaccination to gain humoral immune memory

Clinical and Translational Immunology

Volumn 5, Issue 12, 2016, Pages

  Sarkander, Jana ^a   Hojyo, Shintaro ^a   Tokoyoda, Koji ^a  

^a DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85073682713     PISSN: None     EISSN: 20500068     Source Type: Journal    
DOI: 10.1038/CTI.2016.81     Document Type: Review

References (67)

1. Fenner F. A successful eradication campaign. Global eradication of smallpox. Rev Infect Dis 1982; 4: 916–930.
2. Loomis RJ, Johnson PR. Emerging Vaccine Technologies. Vaccines 2015; 3: 429–447.
3. Willis NJ. Edward Jenner and the eradication of smallpox. Scott Med J 1997; 42: 118–121.
4. Rappuoli R, Miller HI, Falkow S. Medicine. The intangible value of vaccination. Science 2002; 297: 937–939.
5. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47: 401–409.
6. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17: 1055–1065.
7. Seder RA, Darrah PA, Roederer M. T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 2008; 8: 247–258.
8. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006; 6: 741–750.
9. Panum PL. Beobachtungen über das Maserncontagium. Virchows Arch Pathol Med 1847; 1: 492–512.
10. Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272: 54–60.
11. Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A et al. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol 2002; 169: 1277–1282.
12. Kabashima K, Haynes NM, Xu Y, Nutt SL, Allende ML, Proia RL et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J Exp Med 2006; 203: 2683–2690.
13. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature 1997; 388: 133–134.
14. McMillan R, Longmire RL, Yelenosky R, Lang JE, Heath V, Craddock CG. Immunoglo-bulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. J Immunol 1972; 109: 1386–1394.
15. Hibi T, Dosch HM. Limiting dilution analysis of the B cell compartment in human bone marrow. Eur J Immunol 1986; 16: 139–145.
16. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8: 363–372.
17. +) subset in human bone marrow. Immunity 2015; 43: 132–145.
18. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004; 20: 707–718.
19. Winter O, Moser K, Mohr E, Zotos D, Kaminski H, Szyska M et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 2010; 116: 1867–1875.
20. Chu VT, Frohlich A, Steinhauser G, Scheel T, Roch T, Fillatreau S et al. Eosinophils are required for the maintenance of plasma cells in the bone marrow. Nat Immunol 2011; 12: 151–159.
21. Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003; 171: 1684–1690.
22. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 2010; 28: 445–489.
23. Gershon RK, Paul WE. Effect of thymus-derived lymphocytes on amount and affinity of anti-hapten antibody. J Immunol 1971; 106: 872–874.
24. Francus T, Francus Y, Siskind GW. Memory T cells enhance the expression of high-avidity naive B cells. Cell Immunol 1991; 134: 520–527.
25. Crotty S, Kersh EN, Cannons J, Schwartzberg PL, Ahmed R. SAP is required for generating long-term humoral immunity. Nature 2003; 421: 282–287.
26. Park CO, Kupper TS. The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med 2015; 21: 688–697.
27. Esser MT, Marchese RD, Kierstead LS, Tussey LG, Wang F, Chirmule N et al. Memory T cells and vaccines. Vaccine 2003; 21: 419–430.
28. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745–763.
29. Ahlers JD, Belyakov IM. Memories that last forever: strategies for optimizing vaccine T-cell memory. Blood 2010; 115: 1678–1689.
30. Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive as long-term memory cells. Eur J Immunol 2012; 42: 1981–1988.
31. Ise W, Inoue T, McLachlan JB, Kometani K, Kubo M, Okada T et al. Memory B cells contribute to rapid Bcl6 expression by memory follicular helper T cells. Proc Natl Acad Sci USA 2014; 111: 11792–11797.
32. + T cells with commitment to T follicular helper-and T helper 1-cell lineages are generated after acute viral infection. Immunity 2013; 38: 805–817.
33. Pepper M, Pagan AJ, Igyarto BZ, Taylor JJ, Jenkins MK. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 2011; 35: 583–595.
34. MacLeod MK, David A, McKee AS, Crawford F, Kappler JW, Marrack P. Memory CD4 T cells that express CXCR5 provide accelerated help to B cells. J Immunol 2011; 186: 2889–2896.
35. Choi YS, Yang JA, Yusuf I, Johnston RJ, Greenbaum J, Peters B et al. Bcl6 expressing follicular helper CD4 T cells are fate committed early and have the capacity to form memory. J Immunol 2013; 190: 4014–4026.
36. Liu X, Yan X, Zhong B, Nurieva RI, Wang A, Wang X et al. Bcl6 expression specifies the T follicular helper cell program in vivo. J Exp Med 2012; 209: 1841–1852.
37. Tokoyoda K, Zehentmeier S, Hegazy AN, Albrecht I, Grun JR, Lohning M et al. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 2009; 30: 721–730.
38. Shinoda K, Tokoyoda K, Hanazawa A, Hayashizaki K, Zehentmeier S, Hosokawa H et al. Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc Natl Acad Sci USA 2012; 109: 7409–7414.
39. Hanazawa A, Hayashizaki K, Shinoda K, Yagita H, Okumara K, Lohning M et al. CD49b-dependent establishment of T helper cell memory. Immunol Cell Biol 2013; 91: 524–531.
40. Tokoyoda K, Hauser AE, Nakayama T, Radbruch A. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol 2010; 10: 193–200.
41. Tokoyoda K, Radbruch A. Signals controlling rest and reactivation of T helper memory lymphocytes in bone marrow. Cell Mol Life Sci 2012; 69: 1609–1613.
42. Hanazawa A, Lohning M, Radbruch A, Tokoyoda K. CD49b/CD69-dependent generation of resting T helper cell memory. Front Immunol 2013; 4: 183.
43. Okhrimenko A, Grun JR, Westendorf K, Fang Z, Reinke S, von Roth P et al. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory. Proc Natl Acad Sci USA 2014; 111: 9229–9234.
44. Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity 2014; 41: 529–542.
45. Deenick EK, Chan A, Ma CS, Gatto D, Schwartzberg PL, Brink R et al. Follicular helper T cell differentiation requires continuous antigen presentation that is independent of unique B cell signaling. Immunity 2010; 33: 241–253.
46. Baumjohann D, Okada T, Ansel KM. Cutting Edge: distinct waves of BCL6 expression during T follicular helper cell development. J Immunol 2011; 187: 2089–2092.
47. Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol 2000; 165: 5558–5565.
48. Misumi I, Whitmire JK. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol 2014; 192: 1597–1608.
49. Mollo SB, Zajac AJ, Harrington LE. Temporal requirements for B cells in the establishment of CD4 T cell memory. J Immunol 2013; 191: 6052–6059.
50. van Essen D, Dullforce P, Brocker T, Gray D. Cellular interactions involved in Th cell memory. J Immunol 2000; 165: 3640–3646.
51. Whitmire JK, Asano MS, Kaech SM, Sarkar S, Hannum LG, Shlomchik MJ et al. Requirement of B cells for generating CD4+ T cell memory. J Immunol 2009; 182: 1868–1876.
52. +) resting memory T helper cells in the bone marrow. Front Immunol 2016; 7: 26.
53. Baumjohann D, Preite S, Reboldi A, Ronchi F, Ansel KM, Lanzavecchia A et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity 2013; 38: 596–605.
54. Tokoyoda K, Zehentmeier S, Chang HD, Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol 2009; 39: 2095–2099.
55. Hargreaves DC, Hyman PL, Lu TT, Ngo VN, Bidgol A, Suzuki G et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med 2001; 194: 45–56.
56. Mamani-Matsuda M, Cosma A, Weller S, Faili A, Staib C, Garcon L et al. The human spleen is a major reservoir for long-lived vaccinia virus-specific memory B cells. Blood 2008; 111: 4653–4659.
57. Paramithiotis E, Cooper MD. Memory B lymphocytes migrate to bone marrow in humans. Proc Natl Acad Sci USA 1997; 94: 208–212.
58. Gerdts V, Wilson HL, Meurens F, van Drunen Littel-van den Hurk S, Wilson D, Walker S et al. Large animal models for vaccine development and testing. ILAR J 2015; 56: 53–62.
59. Sarkar JK, Mitra AC, Mukherjee MK. The minimum protective level of antibodies in smallpox. Bull World Health Organ 1975; 52: 307–311.
60. Nalin DR, Kuter BJ, Brown L, Patterson C, Calandra GB, Werzberger A et al. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview. J Hepatol 1993; 18(Suppl 2): 51–55.
61. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis 1999; 179: 489–492.
62. Thakur A, Pedersen LE, Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012; 30: 4907–4920.
63. Tuaillon E, Tabaa YA, Petitjean G, Huguet MF, Pajeaux G, Fondere JM et al. Detection of memory B lymphocytes specific to hepatitis B virus (HBV) surface antigen (HBsAg) from HBsAg-vaccinated or HBV-immunized subjects by ELISPOT assay. J Immunol Methods 2006; 315: 144–152.
64. Rojas OL, Caicedo L, Guzman, Rodriguez LS, Castaneda J, Uribe L et al. Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine. Viral Immunol 2007; 20: 300–311.
65. Leyendeckers H, Odendahl M, Lohndorf A, Irsch J, Spangfort M, Miltenyi S et al. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 1999; 29: 1406–1417.
66. Odendahl M, Mei H, Hoyer BF, Jacobi AM, Hansen A, Muehlinghaus G et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood 2005; 105: 1614–1621.
67. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ et al. Multi-functional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843–850.